BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2025 4:19:10 PM | Browse: 21 | Download: 43
 |
Received |
|
2024-10-28 03:41 |
|
Peer-Review Started |
|
2024-10-28 03:41 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-01-10 09:35 |
|
Revised |
|
2025-01-23 09:29 |
|
Second Decision |
|
2025-02-17 02:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-02-17 07:13 |
|
Articles in Press |
|
2025-02-17 07:13 |
|
Publication Fee Transferred |
|
2025-01-26 09:01 |
|
Edit the Manuscript by Language Editor |
|
2025-02-18 17:45 |
|
Typeset the Manuscript |
|
2025-03-02 14:45 |
|
Publish the Manuscript Online |
|
2025-03-25 16:19 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xia Xiao, Qing-Wen Wang, Zheng-Yang Zhou, Lei-Sheng Wang and Pei Huang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Jiangsu Provincial Health and Family Planning Commission Personnel Talent Project |
No. R2017005 |
|
| Corresponding Author |
Lei-Sheng Wang, Wuxi Medical College, Jiangnan University, Binhu Road, Wuxi 214122, Jiangsu Province, China. 6222809140@stu.jiangnan.edu.cn |
| Key Words |
Rectal cancer; Human epidermal growth factor receptor 2; Programmed death 1; Pyrotinib; Chemotherapy; Case report |
| Core Tip |
This human epidermal growth factor receptor 2-amplified advanced rectal cancer was unresponsive to conventional chemotherapy and targeted therapy in a Chinese patient. This study demonstrated the synergistic effect of combining an immune checkpoint inhibitor with pyrotinib, providing a new treatment strategy for patients with advanced rectal cancer. Following treatment with an immune checkpoint inhibitor in combination with pyrotinib, the patient achieved significant therapeutic effects as evidenced by a marked reduction in tumour size. |
| Publish Date |
2025-03-25 16:19 |
| Citation |
<p>Xiao X, Wang QW, Zhou ZY, Wang LS, Huang P. Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report. <i>World J Gastrointest Oncol</i> 2025; 17(4): 102690</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i4/102690.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i4.102690 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
